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Summary
The stimulatory effect of recombinant basic fibroblast growth factor (bFGF) on wound healing
was assessed using healing-impaired (db/db) mice. Full-thickness wounds were made in female
diabetic C57BL/Ksj AM mice, and their normal (db/+) littermates with a punch biopsy
instrument. Recombinant bFGF was applied locally to the open wound once a day. The mice
were later killed and histological sections of the wounds were prepared. The degree of wound
healing was evaluated using several histological parameters such as degree of reepithelialization,
granulation tissue thickness, matrix density, number of infiltrated cells, and number ofcapillaries.
Wounds from normal mice displayed good reepithelialization ratesand granulation tissue formation,
whilewounds from db/db mice had poor responses, especiallyin the dermal parameters. Although
the application of bFGF to wounds in the normal (db/+ ) mice had little effect, application of
bFGF to wounds in AM mice induced significant responses in all of the dermal parameters
compared with nontreated AM mice (p < 0.001). In the presence of bFGF, these parameters
approximated those observed in nontreated littermates. A minimum of 0.5 wg bFGF in either
single or multiple applications was required for a significant effect. bFGF that was either boiled
or pretreated with neutralizing antibody had little stimulatory effect. Time-course experiments
indicated that the granulation response in bFGF-treated mice peaked between 8 and 12 d, and
decreased after 12 d, while matrix density continued to increase until the 18th day (P < 0.05).
The breaking strength of healed linear wounds in AM mice was also decreased when compared
with heterozygous littermates. This parameter was also improved by the administration ofbFGF
to the wounds (p < 0.05).
T
he healing of wounds proceeds in three overlapping
phases: inflammation, granulation tissue formation, and
matrix formation and remodeling (1). This process is believed
to require the interaction ofcells in the dermis and epidermis
as well as the activities of chemical mediators released from
inflammatory cells, fibroblasts, and keratinocytes. Although
the precise interactions of the components comprisingnormal
wound healing are not understood, a number of conditions
such as immunodeficiency, chemotherapy, venous stasis, and
diabetic ulcers result in delayed wound healing (2). One of
the obvious features of full thickness wound healing is the
formation of granulation tissue in the dermis. The prolifera-
tion of mesenchymal cells and capillaries, and the influx of
macrophages that compose the granulation tissue serve to
replace the lost dermis and may also provide substrates and
inducers for reepithelialization.
It has been postulated that the application of agents that
induce fibroblast and/or endothelial cell proliferation to
healing-impaired wounds might increase the rate and degree
of granulation tissue formation and stimulate wound repair.
Several fibroblast mitogens have been tested and appear to
increase wound healing in certain animal systems (3-14). Re-
cently a number of proteins have been characterized as being
inducers ofangiogenesis when applied to specific tissues (15).
The best characterized of these is basic fibroblastgrowth factor
(bFGF)t (16, 17). bFGF is a potent mitogen and chemoat-
tractant for endothelial cells as well as fibroblasts. Therefore,
bFGF appears to be a strong candidate as a potentiating agent
for wound healing. Previous reports (4-7, 10) indicated that
the injection ofbFGF increased granulation tissue formation
in implanted sponges and increased the breaking strength of
incisional wounds in normal rats. However, the effects of
bFGF on the cellular parameters ofwound healing were not
evaluated.
Since the effects ofbFGF on potentiating wound healing
1 Abbreviation used in this paper: bFGF, basic fibroblast growth factor.
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ined, we undertook to characterize this phenomenon. We
describe here a histological evaluation of the effect of bFGF
on woundhealingusinghealing-impaired mice. Mutant dia-
beticmice (db/db)show adelayedhealing response in thedermis
compared with their heterozygous Al+ littermates. The ap-
plication of recombinant bFGF to wounds in AM mice in-
creases the number of infiltrated cells, capillary number, ma-
trix formation, and woundbreaking strength almost to the
levels observed in normal db/+ littermates.
Materials and Methods
Animals.
￿
Female mutant diabetic mice, C57BL/ksJ db/db, and
theirnormal littermates (db/+) were purchasedfrom TheJackson
Laboratory (Bar Harbor, ME). Allmice were maintained on a stan-
dard laboratory diet and water ad libitum, and were used at 8 wk
ofage. At theinitiation ofexperiments, mice were housed individ-
uallyandcheckedforurinary glucose by reagent strips (Miles Labora-
tories Inc., Elkhart, IN). Alldb/db mice were judged to be mildly
to severely diabetic. Mice were maintained in individual cages
throughout the experiment.
Preparation ofReagents.
￿
Recombinant bFGF wasagift from Syn-
ergen, Inc., (Boulder, CO). Carboxymethylcellulose (mol mass 250
kD) was purchasedfrom Polysciences Inc. (Warrington, PA). The
vehicle solution consisted of 1.5%carboxymethylcellulose and0.5%
mouse serumin sterilized PBS solution. Different bFGF solutions
were prepared by adding concentrated recombinant bFGF to the
vehicle solution. pblyclonal antibodies against recombinant bFGF
were raised in rabbits as described (18), and IgG fractions were
prepared by protein A-Sepharose column chromatography and
lyophilized.
Wounding.
￿
Mice were anesthetized with sodium pentobarbital
solution (40 mg/kg, i.p.), and their dorsal hair was clipped. Two
full-thickness round wounds were prepared on the upper back of
each mouse using a punch biopsy instrument (6 mm diameter;
George TiemannandCo., Long Island City, NY). Thetwowounds
were separated by 1 cm in the anterior-posterior direction. After
the operation, 20 /Al of test solution was applied to each wound.
A single mouse received the same test solution in both wounds
to prevent possible effects from leakage from one wound to the
other. The mice were kept anesthetized until the wound was al-
most dry. The wounds were left open during the experiment. In
some experiments, as noted, mice were given dailyapplications of
reagent until the 5th day.
Sample Preparation andHistological Evaluation.
￿
On the indicated
day, the mice were killed by cervical dislocation, using care not
to pull back the skin. The wounds were excised and fixed in 10%
buffered formalin solution. After overnight fixation, the tissue was
trimmed and cut through at the widest margin. The tissue was
embedded in paraffin and sectioned in 5-Am increments. The sec-
tions were made perpendicular to the anterior-posterior axis and
perpendicular to the surfaceof thewound. Six sections were placed
on a slide, and stained with hematoxylin and eosin.
Histological evaluation wasperformedby oneofus (R.T.), with
theidentity ofthesamples masked. Of the sixsections on anyone
slide, the section with thewidest original woundmargin was used
for scoring. Sections that had abscesses were not evaluated. The
parameters measured were degree of reepithelialization, granula-
tion tissue thickness, matrix density, number of infiltrated cells,
and number of capillaries for the entire wound area. Each of the
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parameters was graded numerically as described below to permit
average scores to be compiled.
Reepithelialization.
￿
Thedegree of reepithelialization was mea-
sured and given a value of 0 to 10; 0was equivalent to no closure
and 10 was equivalent to complete reepithelialization by ker-
atinocytes.
Granulation Tissue Thickness.
￿
Avalue of 1 equals a thin granu-
lation layer, 2equals moderate granulation, 3 equals athick granu-
lation layer, and 4 equals a very thick granulation layer.
Matrix Density.
￿
The degree of dermal matrix deposition was
scored as 1 equals edematous with little matrix, 2 equals a small
amount of coarse matrix, 3 equals a moderate amount of matrix,
and 4 equals dense matrix.
Infiltrated Cells.
￿
As an index of the degree of cellular infiltra-
tion, the number of fibroblasts and macrophages was estimated.
Polymorphonuclear cellsandlymphocytes were excluded from the
counting. Ascoreof 1 equals fewcells, 2 equals amoderate number,
3 equals many cells, 4 equals very many cells.
Capillary Number.
￿
Thenumber ofcapillary lumens wascounted
in thecomplete woundcross-section at x100magnification. Ascore
of 0 equals 0-4 capillaries perwound, 1 equals 5-14 capillaries per
wound, 2 equals 15-24 capillaries per wound, etc. Only mature
vessels that contained erythrocytes were counted.
Breaking Strength:
￿
Full thickness, anterior-posterior incisional
wounds (4 cm) were made on theback with ascalpel. Afterappli-
cation of bFGF or vehicle solution, the incision was closed using
with four monofilament nylon sutures (5-0; Ethicon Inc., Som-
merville, NJ) placed at 1 cm intervals. Mice were killed on post-
wounding day 9, sutures were removed, and three strips of skin
(0.8 cm wide) were takenperpendicular to thewound andbetween
the sutures. The edges ofthe original woundwere not used. The
first strip was used for histological evaluation, and the other two
strips were kept wet with PBS and used for tensile strength mea-
surements. Breaking strength was measured using a spring bal-
ance (maximum 250 g; Ohaus Scale Corp., Florham Park, NJ).
The ends of the wound were secured by binder clips (1/2 inch;
Swingline, Inc., Long Island City, NY). Aforcewasapplied across
the incision at a constant speed (1 cm/s). The breaking strength
was thepointof maximalstress before wound separation, and was
expressedas g/mm incisional width. Measurements were done with
the investigator blinded as to sample origin.
Statistical Analysis.
￿
Allthedata were analyzed by Student'spaired
t-test. Results were expressed as means ± SEM. The differences
in measurements betweenthe twowounds on a single mousewere
nevergreater than thedifferences observed betweenidentical mice.
Results
Ourinitial attempts to measurethe effect ofbFGF on full-
thickness wounds in normal BALB/c and C57BL mice indi-
cated that theapplication ofthe growth factor hadonly small
positive effects (data not shown). As shownin Table 1, normal
C57BL/ksJ db/+ mice had good wound closure rates and
granulation tissue formation. The application ofbFGF to these
wounds hadaminimaleffect on thewound healingparameters
(Table 1) . Typical examples of the histology of the wounds
from treated vs. nontreated Al + mice areillustrated in Fig.
1, a and b. It is apparent that reepithelialization was com-
pleted by 8 d after wounding and thick granulation tissue
was formed in both specimens. It should be noted that al-Samples were taken at 8 days post-wounding. Vehicle solutions plus and nnnus bFGF as indicated were applied each day for five days begin-
ning with the day of wounding . Scoring of each parameter was graded by the method described in the text. hg refers to the amount of
bFGF applied . n, Number of wounds analyzed .
' Value is different from that of control db/+ mice, 0 Etg x 5 d, p< 0.02 .
#p < 0.001 .
5 Asterisks indicate that the values are significantly different from that of dbldb mice, 0 Atg x 5 d, p< 0.05 .
though reepithelialization was complete in the samples illus-
trated in Fig . 1, a and b, in the majority ofthe samples (Table
1), reepithelialization was only 80-90% at this time . The
dermal layer appears to be somewhat thicker in the treated
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wound illustrated, but this was not always observed . At the
higher magnification, infiltrated macrophages, fibroblasts, and
lymphoid cells as well as capillaries were evident in both non-
treated and treated wounds . Thus, no major differences were
Figure 1 .
￿
Photomicrographs of wound specimens from dbldb and db/+ littermates. Sections were prepared and stained as described in
Materials and Methods . Top panels, x30 ; bottom panels, x140 . Each photomicrograph was taken from a section prepared for the experiments
presented in Table 1. Arrowheads indicate the original wound margins. (a) Section from a wound from a nontreated normal mouse (dbl+) at 8
d after wounding . (b) Section from a wound from a normal mouse (dbl+) at 8 d after the treatment with 5 Wg of bFGF per day for 5 d. (c)
Section from a wound from a nontreated dbldb mouse at 8 d after wounding. (d) Section from wound from a dbldb mouse at 8 d after treat-
ment with 5 Pg of bFGF per day for 5 d. The scoring for the healing parameters for these four samples with respect to reepithelialization,
granulation tissue thickness, matrix density, infiltrated cells, and capillary numbers were, respectively : (a) 10, 3, 4, 3, and 6; (b) 10, 2, 4, 4, and
11; (c) 4, 1, 1, 1, and 2 ; (d) 10, 3, 4, 3, and 12.
Table 1 . Effects of bFGF
Treatment
on
n
Wound Healing in Normal
Reepithelialization
and dbldb Mice
Granulation
tissue thickness
Matrix
density
Infiltrated
cells
Capillary
number
Normal Mice (dbl+ )
0ugbFGF x 5d 10 8.8±0.6 3.3±0.1 3.3±0.3 3.2±0.2 8.1±0.8
Normal Mice (dbl+ )
5ug x 5d 9 8.6±0.7 3.6±0.2 3.4±0.3 3.8±0.1' 10.6±'1 .3
dbldb Mice
0 ug x 5 d 10 7 .1 ± 0.7 1.4 ± 0.2 2.1 ± 0.4 1 .7 ± 0.1 2.4 ± 0.4
dbldb Mice
5 ug x 5 d 10 8 .4 ± 0.6 2.8 ± 0.2# 3 .1 ± 0.25 2.8 ± 0.2# 8.2 ± 0.9#observed between the control and the treated wounds in dbl+
mice.
When wound healing in the dbl+ mice was compared
with that in the homozygous dbldb littermates, an impair-
ment in dermal wound healingwas obvious in the AM mice
(Table 1 and Fig. 1 c). At 8 d after wounding there was a
slight decrease in the degree of reepithelialization, and sig-
nificantly less granulation tissue formation, cellular infiltra-
tion, and neovascularization under normal conditions of
wound repair when theAM mice were compared with Al+
mice (Table 1). The decrease of the healing response is quite
evident by the absence of granulation tissue at this time (Fig.
1 c). Instead of an influx of fibroblasts, macrophages, and
blood vessels, the dermal layer is occupied by adipose tissue.
The incompletely reepithelialized epidermis is covered by a
thick crust. The widerwoundborder seen in the AM animals
(Fig. 1 c) when compared with those in the dbl+ animals
(Fig. 1 a) probably results from the distension of the skin
in the obese dbldb animals.
When bFGF (5 jig) was applied to wounds in dbldbmice,
significant responses were observed in granulation tissue thick-
ness (p < 0.001), matrix density (p < 0.05), infiltrated cells
(p < 0.001), and capillary numbers (p < 0.001). The increase
in granulation tissue was obvious when the excised treated
and nontreatedwounds were observed from the dermal side
before sectioning. There was a slight increase in the degree
of reepithelialization (Table 1), but this was probably not
statistically significant (see below). A typical cross-section
of a bFGF-treated wound in dbldb mice (Fig. 1 d) illustrates
a significant increase of granulation tissue when compared
with the untreated dbldbwound (Fig. 1 c). The dermis con-
tains large numbers of fibroblasts and macrophages, and
numerous capillaries are evident. Thus, with the application
ofbFGF to wounds indbldbmice, the degree ofwound healing
approximated that observed in the control heterozygous
(dbl + ) mice.
The dose of bFGF required to stimulate healing in dbldb
mice was next established. Doses of 0.05, 0.5, and 5 jig of
bFGF were applied to the wounds once a day for 5 d. The
wounds fromdbldbmice that received no bFGF again demon-
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strated impaired wound repair with thin granulation tissue,
few infiltrated cells, and decreased capillary numbers. With
the application of 0.05 ug/d ofbFGF, there was no statisti-
cally valid effect on these parameters when compared with
the nontreated mice. However, with the application of 0.5
or 5 wg/d of bFGF, strong increases in all of the dermal
parameters were observed. The number of capillaries was
significantly higher than that found in nontreated mice (p
< 0.001 at 0.5 hg/d and p < 0.01 at 5 lAg/d). Thus, the effec-
tive dose ofbFGF required for a significant increase in wound
healing is between 0.05 and 0.51~g/d when applied multiple
times. These treatments had little or no effect on the degree
of reepithelialization (Table 2). It is not clear why the av-
erage control values in this experiment differed from those
observed in the experiment presented in Table 1. However,
although the absolute values were different, the effect of the
bFGF treatment was qualitatively equivalent between experi-
ments. Wounds in heterozygous dbl+ littermates did not
show a response to these concentrations of bFGF in the
parameters measured (data not shown) presumably because
the normal healing could not be accelerated.
Since Davidson et al. (7) reported that iodinated carti-
lage-derived growth factor, which appears to be a form of
bFGF, disappeared from wounds within 24 h afterinjection,
we next tested whether there were significant differences in
healing between single vs. multiple applications of growth
factor. As shown in Table 3, single dosing at 0.5 as well as
5 Fcg gave responses essentially equivalent to multiple doses
at 5 ug with the exception of the increase in matrix density.
To insure that measured effects actually resulted from the
bFGF in the preparations, two additional experiments were
conducted. Boiled bFGF (5 ;&g/d) failed to induce statisti-
cally significant increases in the numbers of infiltrated cells
or capillaries (Table 3). Furthermore, pretreatment ofthe bFGF
with anti-bFGF IgG blocked the stimulation of wound
healing, but treatment with nonimmune IgG did not (Table
3). These data clearly showed that bFGF was responsible for
the observed histological responses.
To measure the effects ofbFGF on wound healing in AM
mice as a function of time, histological sections of treated
Samples were taken at 8 d after wounding. Solutions were applied once a day each day for 5 d beginning with the day of wounding. ug, the
amount of bFGF applied. Scoring of each parameter was graded by the method described in the text . n, number of wounds analyzed.
Asterisks indicate that the values are significantly different from that of control (0 Fag x 5 d).
' p < 0.01.
t p < 0.001.
Table 2. Dow Effect on Wound Healing in db/db Mice
Granulation Matrix Infiltrated Capillary
Treatment n Reepithelialization tissue thickness density cells number
0jAg x 5d 10 5.0±0.6 1 .6 ± 0.2 1.8 ± 0.2 1 .8 ± 0.2 4.2 ± 1.0
0.05 lAg x 5 d 10 5.0 ± 0.7 1.7 ± 0.1 1.9 ± 0.2 2.6 ± 0.3 6.8 ± 1.2
0.5lAg x 5d 5 5.6±1 .1 2.8 ± 0.2" 2.2 ± 0.3 3.0 ± 0' 12.8 ± 1.0
5ug x 5d 8 4.3±0.9 3.0 ± 0.3' 3.6 ± 0.2t 3.8 ± 0.2# 13.8 ± 2 .9'and nontreated wounds were prepared at 5, 8, 12, and 18 d
after wounding (Table 4). All of the granulation parameters
measured in bFGF-treated wounds exceeded those in non-
treated mice at all days (p < 0.1 to p < 0.001). In general,
the responses in the treated wounds occurred earlier and were
more extensive than those observed in the nontreated wounds.
However, significant differences were not seen with respect
to effects on wound closure. All ofthe granulation parameters
in bFGF-treated mice increased for the first 12 d. Interest-
ingly, between 12 and 18 d, the granulation response appeared
to begin to resolve as measured by decreases in the thickness
of the granulation tissue, the number ofinfiltrated cells, and
the number of capillaries. Meanwhile, matrix density con-
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Samples were taken at 8 d after wounding. Scores of each parameter were established by the method described in the text. Wg, the amount of
bFGF applied. n, number of wounds analyzed.
tinued to increase, suggesting that matrix maturation and
remodeling were occurring.
We next attempted to measure breaking strength ofbFGF-
treated and control incisional wounds to determine whether
increased matrix formation strengthened the healing wound.
Fig. 2 illustrates the results of breaking strength measure-
ments in dbldb and dbl+ wounds. Wounds from mutant AM
mice broke at 56% of the breaking strength of wounds from
normal heterozygous littermates. Application of a single dose
ofbFGF increased the breaking strength in wounds from Al+
mice by 24% and that in AM mice by 46% (p < 0.05). As
a result ofbFGF application, breaking strength in bFGF-treated
wounds from AM mice approximated that in healed wounds
Samples were taken at designated days. Scores of each parameter were graded by the method described in the text. Statistical evaluation was
done between treated and nontreated mice on the same days. Superscripts indicate that the values are significantly different. n, number of
wounds analyzed.
p < 0.001 .
#p < 0.01.
Sp < 0.05.
II p < 0.02.
1p < 0.1.
Table 3. Effects of bFGF on Wound Healing in dbldb Mice
Granulation Matrix Infiltrated Capillary
Treatment n Reepithelialization tissue thickness density cells number
Vehicle alone x 5 d 9 6.1 ± 0.9 1.9 ± 0.1 2.1 ± 0.3 1.8 ± 0.1 5.2 ± 0.6
Vehicle alone x 1 d 8 7.5 ± 0.8 1.6 ± 0.2 1.9 ± 0.2 1.9 ± 0.3 7.5 ± 1.5
0.5 lAg x 1 d 10 6.4 ± 0.7 2.5 ± 0.2 2.5 ± 0.2 2.5 ± 0.2 12.1 ± 1.1
5pg x id 8 8,9 ± 0.5 2.8 ± 0.2 2.8 ± 0.2 2.9 ± 0.1 13.5 ± 1.3
5jgx5d 10 5.3 ± 0.7 2.5 ± 0.2 2.2 ± 0.2 2.6 ± 0.2 12 .9 ± 1.8
5 ug boiled x 5 d 9 6.2 ± 0.6 1.6 ± 0.2 2.0 ± 0.2 2.0 ± 0.2 7.1 ± 0.9
(0.5 wg + anti-bFGF IgG) x 1 d 7 7.0 ± 1.0 2.1 ± 0.1 2.0 ± 0 2.1 ± 0.1 7.9 ± 1.6
(0.5 hg + non-immune IgG) x 1 d 7 6.7 ± 0.9 2.9 ± 0.1 2.9 ± 0.2 2.9 ± 0.2 14.3 ± 2.1
Table 4. Time Course of Wound Healing in dbldb Mice With and Without bFGF
Granulation Matrix Infiltrated Capillary
Treatment n Reepithelialization tissue thickness density cells number
0ug x 5d 10 1.7±0.2 1.3 ± 0.1 1.0 ± 0 1.3 t 0.1 1.8 ± 0.6
8 d 9 3.6 ± 0.6 1.2 ± 0.1 1.1 ± 0.1 1.4 ± 0.2 3.4 ± 1.3
12 d 9 7.7 ± 0.6 2.0 ± 0.2 2.3 ± 0.2 2.1 ± 0.2 5.8 ± 0.8
18 d 11 10.0 ± 0 1.7 ± 0.2 3.0 ± 0.2 2.0 ± 0.2 7.0 ± 0.9
5 lg x 5 d 10 2.0 ± 0.2 1.3 ± 0.1 1.0 ± 0 1.4 ± 0.2 3.4 ± 1.1
8 d 8 3.8 ± 0.7 2.6 ± 0.2' 2.1 ± 0.2` 2.6 ± 0.2" 11.9 ± 2.7t
12 d 10 7.9 ± 0.9 2.9 t 0.3S 3.2 ± 0.2# 3.2 ± 0.2# 16.8 ± 1.9"
18 d 10 10.0 ± 0 2.3 ± 0.111 3.6 ± 0.2S 2.5 ± 0.21 10.4 ± 0.911Figure 2.
￿
Tensile strength
measurements . Wounds were
prepared as described in the
text . The breaking strength
was measured and expressed as
g/mm incisional width . (1)
Wounds from nontreated dbl+
mice, (1) wounds from dbl+
mice treated with 5 Rg of
bFGF, (3) wounds from non-
treated dbldb mice, (4) wounds
from dbldb mice treated with 5
kg of bFGF. Asterisks indicate
the statistical evaluation be-
tween treated and nontreated
mice. p < 0.05 . Bars : SEM.
of nontreated db/+ littermates. Histological evaluation of
wound tissues taken from the same mice showed results similar
to those seen earlier in Table 1 and Fig . 1 (data not shown) .
These data suggest that the increased granulation tissue ob-
served by histological evaluation contributes to an increase
of the strength of the repaired wound .
Discussion
These experiments provide histological evidence that recom-
binantbFGF is capable of significantly improving the degree
of dermal healing in dbldb mice . The observed increases in
granulation tissue thickness, infiltrated cells, capillary number,
and tensile strength are consistent with the proposal thatbFGF
is an inducer of granulation . Besides bFGF, other polypep-
tide growth factors, such as platelet-derived growth factor
(PDGF), TGF-a, epidermal growth factor (EGF), and TGF-(3
have been shown to increase various parameters of wound
healing (3, 8, 9, 11-14, 19-21) .
Unlike EGF, bFGF appeared to have little effect on the
degree of reepithelialization . Since keratinocytes respond to
bFGF (22, 23), this result was somewhat surprising. Perhaps,
the presence of the large scab, which formed because we used
an open wound system, affected the migration of keratino-
We thank Melinda Vassallo for her excellent technical assistance.
cytes . Therefore, it will be of interest to test the effect of
bFGF on wounds with occlusive dressings.
It is also interesting that only a small effect of bFGF on
the rate or degree of healing in normal mice was observed,
although there are several reports that demonstrate positive
effects of bFGF on wounds in normal rats using different
assays (4-7, 10) . It is possible that normal mice have sufficient
amounts of growth factors to achieve a maximal rate ofhealing,
and therefore, only minor increases in wound repair are pos-
sible upon the application of exogenous growth factors . The
histological measurements that we used may not have been
sensitive enough to detect these small effects .
Mutant diabetic mice (dbldb) have elevated blood sugar levels,
increased or normal insulin concentrations, and suppressed
cell-mediated immunity (24) . They are also obese with dis-
tended, thin skin . Thus, the reason for their impaired rate
ofwound healing may be complicated and multifactorial . It
is known that glucocorticoid-treated rats have delayed wound
healing and that TGF-a reverses this effect (13) . Rats with
chemically induced diabetes have a decreased rate of collagen
deposition which can be restored to a normal level by the
application ofPDGF (8) . It is also likely that the presence
ofmacrophages has a strong effect on the formation ofwound
granulation tissue (25), and that macrophage accumulation
is impaired in dbldb mice. The mechanism responsible for
impaired wound healing in dbldb mice is unknown at this
time and remains to be elucidated .
The effective dose of bFGF required for a significant in-
crease in wound healing was established to be 0.5 NAg/d using
either single or multiple applications. The reason why a single
dose was as effective as multiple doses is not clear but may
relate to the recruitment of macrophages and fibroblasts by
the bFGF . These migratory cells may be responsible for sub-
sequent events at wound sites in the absence of appliedbFGF.
It is also interesting, and perhaps important, that multiple
doses of high concentrations ofbGFG did not induce un-
limited granulation tissue formation, and after reepitheliali-
zation a decrease in the amount of granulation tissue and
matrix occurred . This suggests that bFGF can be used as a
self-limited, potent wound healing-potentiating agent .
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